Aurora Cannabis Inc (21P.MU)

4.4350

+0.2550

+(6.10%)

As of 12:49:24 PM GMT+2. Market Open.

Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX, ACB

Exec Edge announced the formal launch of Exec Edge Research, a platform that will publish detailed initiation notes along with quarterly updates.

PR Newswire 3 days ago

ACB

CLYM

REX
Higher Returns with Aurora Cannabis – Initiation Report

Visit Exec Edge Research for Full Report By Rayk Riechmann Investors want what they’re on! Aurora Cannabis Inc. (Nasdaq: ACB), a federally-licensed producer of medical and consumer cannabis, is attractively positioned as an early leader in global regulated markets. ACB leverages a best-in-class brand portfolio to grow and sell products across all major cannabis categories. […]

Exec Edge 4 days ago

ACB
Is Aurora Cannabis Inc. (ACB) Among the Best Tobacco and Cigarette Stocks to Buy Now?

We recently compiled a list of the 10 Best Tobacco and Cigarette Stocks to Buy Now. In this article, we are going to take a look at where Aurora Cannabis Inc. (NASDAQ:ACB) stands against the other Tobacco and Cigarette stocks. Cigarette and tobacco stocks are companies that produce and sell cigars, snuff, chewing tobacco, cigarettes, e-cigarettes, […]

Insider Monkey 11 days ago

ACB
Aurora Cannabis Announces the Completion of a Multimillion Dollar Investment and Renaming of B.C. Manufacturing Facility

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the completion of a multi-year investment of $3 million in improvements to its manufacturing facility in Pemberton, British Columbia. These upgrades are a combination of Aurora's proprietary high-performing genetics and state-of-the-art engineering design which have resulted in optimal cultivation conditions, expanded output, and superior product quality. The site has been renamed

CNW Group 12 days ago

ACB
Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the availability of medical cannabis concentrates to patients in the United Kingdom (UK). This launch marks the company's meaningful step in offering its proprietary cultivar-specific inhalable cannabis extracts in the UK market. These products are available to patients in Canada and Australia and this launch reinforces Aurora's commitment to expanding patient access to

CNW Group 27 days ago

ACB
Aurora Cannabis Recognized for Executive Gender Diversity by The Globe and Mail

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has been named an honouree on the Globe & Mail's 2025 Report on Business, Women Lead Here list. This annual editorial benchmark recognizes the top publicly traded Canadian companies with the highest gender diversity at the executive level.

CNW Group last month

ACB
Is Aurora Cannabis Inc. (ACB) the Best Cannabis Stock to Buy According to Billionaires?

We recently published a list of 12 Best Cannabis Stock to Buy According to Billionaires. In this article, we are going to take a look at where Aurora Cannabis Inc. (NASDAQ:ACB) stands against other best marijuana stocks to invest in according to billionaires. 2025 didn’t start off very well for the American cannabis sector. The recent […]

Insider Monkey last month

ACB
Aurora Cannabis to Speak at the Global Cannabis Regulatory Summit

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to be attending, sponsoring and speaking at the 2025 Global Cannabis Regulatory Summit (GCRS), held within the U.S. Capitol Complex in Washington, D.C. on March 26-27, 2025.

CNW Group last month

ACB
TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside

After bursting onto the scene several years ago with considerable fanfare, much of the hype about cannabis stocks has quietly died down, and share prices have largely followed suit. Here, we’ll examine three profitable and cheap cannabis-related stocks that offer investors long-term value and potential upside: Turning Point Brands (TPB), Aurora Cannabis (ACB), and Jazz Pharmaceuticals (JAZZ). Cannabis Potential Released From Government Dungeons Having been illegal for decades, cannabis is seeing

TipRanks last month

JAZZ

TPB

ACB
Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in cannabis sativa. The development of this proprietary genetic marker technology, which is now in use in Aurora's breeding program, is set to produce powdery mildew resistant cultivars that will be explored for commercial

PR Newswire last month

ACB
Aurora Cannabis Rides the Global Legalization Wave: Should You Invest?

ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics and deep regulatory knowledge.

Zacks last month

ACB
Are Medical Stocks Lagging Aurora Cannabis (ACB) This Year?

Here is how Aurora Cannabis Inc. (ACB) and Concentra Group (CON) have performed compared to their sector so far this year.

Zacks last month

ACB
Is Aurora Cannabis (ACB) Stock Outpacing Its Medical Peers This Year?

Here is how Aurora Cannabis Inc. (ACB) and AdaptHealth Corp. (AHCO) have performed compared to their sector so far this year.

Zacks 2 months ago

ACB

AHCO
Wall Street Analysts Predict a 25.67% Upside in Aurora Cannabis (ACB): Here's What You Should Know

The mean of analysts' price targets for Aurora Cannabis (ACB) points to a 25.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks 2 months ago

ACB
Best Momentum Stocks to Buy for February 21st

ACB, BHRB and BJ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 21, 2024.

Zacks 2 months ago

BJ

ACB
Best Value Stocks to Buy for February 21st

ACB, and PRTH made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 21, 2024.

Zacks 2 months ago

ACB

PRTHU
Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the company's extended pastille offerings in Australia. This expansion marks another meaningful step in Aurora's deep commitment to offering patients a diverse range of high-quality, premium medical cannabis products to meet their various needs and interests.

PR Newswire 2 months ago

ACB
Aurora Cannabis Skyrockets After Earnings: Should You Buy Into the Rally?

The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025. Shares of Aurora got a big boost after the company posted its latest earnings numbers showing a strong profit. Could this be a turning point for Aurora after years of disappointment?

Motley Fool 2 months ago

ACB
All You Need to Know About Aurora Cannabis (ACB) Rating Upgrade to Strong Buy

Aurora Cannabis (ACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks 2 months ago

ACB
Is Beam Therapeutics (BEAM) Outperforming Other Medical Stocks This Year?

Here is how Beam Therapeutics Inc. (BEAM) and Aurora Cannabis Inc. (ACB) have performed compared to their sector so far this year.

Zacks 2 months ago

BEAM

ACB

Performance Overview

Return	21P.MU	S&P/TSX Composite index (^GSPTSE)
YTD	+8.97%	+2.99%
1-Year	-29.77%	+13.67%
3-Year	-79.45%	+28.73%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

TARIFFS LATEST

Aurora Cannabis Inc (21P.MU)

Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX, ACB

Higher Returns with Aurora Cannabis – Initiation Report

Is Aurora Cannabis Inc. (ACB) Among the Best Tobacco and Cigarette Stocks to Buy Now?

Aurora Cannabis Announces the Completion of a Multimillion Dollar Investment and Renaming of B.C. Manufacturing Facility

Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom

Aurora Cannabis Recognized for Executive Gender Diversity by The Globe and Mail

Is Aurora Cannabis Inc. (ACB) the Best Cannabis Stock to Buy According to Billionaires?

Aurora Cannabis to Speak at the Global Cannabis Regulatory Summit

TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside

Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars

Aurora Cannabis Rides the Global Legalization Wave: Should You Invest?

Are Medical Stocks Lagging Aurora Cannabis (ACB) This Year?

Is Aurora Cannabis (ACB) Stock Outpacing Its Medical Peers This Year?

Wall Street Analysts Predict a 25.67% Upside in Aurora Cannabis (ACB): Here's What You Should Know

Best Momentum Stocks to Buy for February 21st

Best Value Stocks to Buy for February 21st

Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia

Aurora Cannabis Skyrockets After Earnings: Should You Buy Into the Rally?

All You Need to Know About Aurora Cannabis (ACB) Rating Upgrade to Strong Buy

Is Beam Therapeutics (BEAM) Outperforming Other Medical Stocks This Year?

Performance Overview